Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: A survey by the gynecologic oncology committee of Japan Society of Obstetrics and Gynecology

N Tsuda,K Ushijima,M Mikami,W Yamagami,A Mitsuhashi,M Shozu,T Enomoto,N Yaegashi

doi:10.1016/j.ygyno.2020.05.620

Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: A survey by the gynecologic oncology committee of Japan Society of Obstetrics and Gynecology

N Tsuda, K Ushijima + Show 6 more

https://doi.org/10.1016/j.ygyno.2020.05.620

Copy DOI

Journal: Gynecologic Oncology	Publication Date: Oct 1, 2020
Citations: 1

Affiliation: Kurume University, Tokai University, Keio University, Chiba University, Niigata University, Tohoku University

#Treatment For Atypical Endometrial Hyperplasia #Cancer Patients In Japan + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Objective: Fertility-sparing treatment is an option for young patients with atypical endometrial hyperplasia (AEH) and endometrial cancer. However, its clinical features and current trends in treatment are relatively unknown in Japan. In this study, we aimed to collect and analyze nationwide data on fertility-sparing treatment for AEH and endometrial cancer patients in Japan. The objective of this study was to examine pathological complete remission (CR) rates and trends in fertility-sparing treatment for young AEH and endometrial cancer patients in Japan.

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Gynecologic Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.